EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Certolizumab pegol for hidradenitis suppurativa: A systematic review

Abdul Aziz Abdul Ghafoor, Sherilyn Wen, Samiha Mohsen, Afsaneh Alavi, Vincent Piguet

Journal of the American Academy of Dermatology · 2026-09

DOI: 10.1016/j.jaad.2026.09.103 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of the American Academy of Dermatology, 2026-09. Verfasst von Abdul Aziz Abdul Ghafoor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: azizg12@student.ubc.ca. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hidradenitis suppurativa (HS) is a chronic inflammatory disorder causing recurrent intertriginous nodules and abscesses.1 Biologic therapies, including tumor necrosis factor-alpha inhibitors (eg, adalimumab), are key therapeutic options for patients with moderate-to-severe HS.1 In adalimumab phase 3 trials,

Schlagwörter

Stichwörter der Autor:innen

biologicscertolizumabhidradenitis suppurativatumor necrosis factor-α

Autor:innen und Institutionen

  • Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: azizg12@student.ubc.ca.
  • Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Division of Dermatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
  • Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada.

Zitieren

APA

Abdul Ghafoor, A. A., Wen, S., Mohsen, S., Alavi, A., & Piguet, V. (2026). Certolizumab pegol for hidradenitis suppurativa: A systematic review. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.09.103

Vancouver

Abdul Ghafoor AA, Wen S, Mohsen S, Alavi A, Piguet V. Certolizumab pegol for hidradenitis suppurativa: A systematic review. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.09.103

BibTeX
@article{AbdulGhafoor2026,
  author = {Abdul Ghafoor, Abdul Aziz and Wen, Sherilyn and Mohsen, Samiha and Alavi, Afsaneh and Piguet, Vincent},
  title = {Certolizumab pegol for hidradenitis suppurativa: A systematic review},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  doi = {10.1016/j.jaad.2026.09.103}
}
Kostenlos starten →